Innovation week in Abu Dhabi wrapped up
Abu Dhabi wrapped up the activities of “DoH Innovation Week 2023”, which included the announcement of the winners of the Healthcare Research and Innovation Grant and a series of panel discussions that tapped into several areas of innovation, such as, supporting entrepreneurs, design thinking, Artificial Intelligence (AI), and the National Innovation Strategy. This comes as part of DoH’s efforts to cement Abu Dhabi’s position as a leading destination for innovation in healthcare and a hub life sciences.
Recent Posts
Inflation Reduction Act Impact on Clinical Trial Investment Trends
The Inflation Reduction Act Impact is becoming evident in early data on industry-sponsored clinical trials. A recently published JME article examines how the Drug Price Negotiation Program (DPNP) introduced by the IRA may be altering investment incentives for biopharmaceutical innovation.
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application Amid Regulatory Hurdles
Anavex Life Sciences has withdrawn its marketing authorization application for blarcamesine in early Alzheimer’s disease following feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). EU Alzheimer Approval Challenges remain a significant hurdle for ...
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer Treatment
NICE Pembrolizumab recommendation offers a major advance for adults with resectable locally advanced head and neck squamous cell carcinoma. This update provides an evidence-based overview of the final draft guidance issued by NICE recommending pembrolizumab, within its marketing authorisation, fo...